Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Mar 16 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-16-2024

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 16, 2024, titled "Zydus receives final approval from USFDA and 180 days CGT exclusivity for Finasteride and Tadalafil Cap Capsules".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases